GURUFOCUS.COM » STOCK LIST » USA » NAS » CollPlant Biotechnologies Ltd (NAS:CLGN) » Definitions » Financial Strength
Switch to:

CollPlant Biotechnologies Financial Strength

: 7 (As of Mar. 2022)
View and export this data going back to 2021. Start your Free Trial

CollPlant Biotechnologies has the Financial Strength Rank of 7.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

CollPlant Biotechnologies did not have earnings to cover the interest expense. CollPlant Biotechnologies's debt to revenue ratio for the quarter that ended in Mar. 2022 was 12.98. As of today, CollPlant Biotechnologies's Altman Z-Score is 9.76.


Competitive Comparison

For the Biotechnology subindustry, CollPlant Biotechnologies's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

CollPlant Biotechnologies Financial Strength Distribution

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's Financial Strength distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's Financial Strength falls into.



CollPlant Biotechnologies Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

CollPlant Biotechnologies's Interest Expense for the months ended in Mar. 2022 was $-0.09 Mil. Its Operating Income for the months ended in Mar. 2022 was $-3.77 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was $2.92 Mil.

CollPlant Biotechnologies's Interest Coverage for the quarter that ended in Mar. 2022 is

CollPlant Biotechnologies did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

CollPlant Biotechnologies's Debt to Revenue Ratio for the quarter that ended in Mar. 2022 is

Debt to Revenue Ratio=Total Debt (Q: Mar. 2022 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.513 + 2.915) / 0.264
=12.98

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

CollPlant Biotechnologies has a Z-score of 9.76, indicating it is in Safe Zones. This implies the Z-Score is strong.

Good Sign:

Altman Z-score of 9.76 is strong.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CollPlant Biotechnologies  (NAS:CLGN) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

CollPlant Biotechnologies has the Financial Strength Rank of 7.


CollPlant Biotechnologies Financial Strength Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


CollPlant Biotechnologies Business Description

CollPlant Biotechnologies logo
Traded in Other Exchanges
N/A
Address
4 Oppenheimer Street, Weizmann Science Park, Rehovot, ISR, 7670104
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.

CollPlant Biotechnologies Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)